Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ASPC | A Spac III Acquisition Corp. | $28.24 | $14.82 | 110.43% | 5.5M | $31M | $9.95$63.98 |
| GSIT | Gsi Technology | $8.54 | $2.48 | 40.92% | 11.4M | $214M | $1.62$18.15 |
| JLHL | Julong | $4.64 | $0.95 | 25.75% | 74.5K | $78M | $2.70$6.30 |
| GLTO | Galecto | $35.80 | $6.31 | 21.40% | 199.3K | $47M | $2.01$38.33 |
| RAY | Raytech | $2.31 | $0.38 | 19.70% | 176.9K | $5.3M | $1.40$58.88 |
| QBTZ | Tidal Trust II - Defiance Daily Target 2x Short Qbts ETF | $10.60 | $1.73 | 19.50% | 3.6M | - | $6.62$32.28 |
| SHMD | Schmid Group | $5.99 | $0.97 | 19.36% | 759.3K | $244M | $1.86$6.70 |
| IKT | Inhibikase Therapeutics | $1.97 | $0.32 | 19.09% | 1.6M | $200M | $1.33$3.49 |
| UPC | Universe Pharmaceuticals Inc | $5.10 | $0.82 | 19.02% | 3.2M | $2.4M | $2.51$28.00 |
| RGTZ | Tidal Trust II - Defiance Daily Target 2x Short Rgti ETF | $21.38 | $2.90 | 15.69% | 2.5M | - | $8.14$37.48 |
Related Articles
Featured Article
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Jia Jie Chen|Apr 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
This Was the Top-Performing IPO in 2020
Rick Munarriz|Dec 28, 2020
A lot of buzz-generating IPOs have more than tripled in 2020, but you probably don't know the top U.S. debutante that has soared 583% this year.
Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Zhiyuan Sun|Dec 10, 2020
Greenwich LifeSciences made investors rich overnight. Is there any growth left in this breast cancer treatment developer?
Advertisement